Beam Therapeutics Inc

NASDAQ:BEAM  
48.20
+3.51 (+7.85%)
Earnings Announcements

Beam Therapeutics Announces Business And Pipeline Progress And Reports Third Quarter 2020 Financial Results

Published: 11/10/2020 11:48 GMT
(BEAM) - Beam Therapeutics Announces Business and Pipeline Progress and Reports Third Quarter 2020 Financial Results.
Q3 Loss per Share $0.69.
Q3 Earnings per Share Estimate $-0.56 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.65

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.66

More details on our Analysts Page.